Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Combination Therapy of Sorafenib With Mesenchymal Stem Cells As a Novel Cancer Treatment Regimen in Xenograft Models of Hepatocellular Carcinoma
Iman Seyhoun
Iman Seyhoun

Assistant Professor of Applied Cellular Sciences

Department Tissue Engineering and Applied Cellular Sciences

School of Advanced Technologies in Medicine

Iranian Tissue Bank & Research Center

Tehran University of Medical Sciences

All Documents
12. Implication for Prevention and Control of Cardiovascular Disease; an Experience From Iran, Scientific Journal of Kurdistan University of Medical Sciences (2021)
14. Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of Hcc, Evidence-based Complementary and Alternative Medicine (2020)